Chronic Pain News and Research

RSS

Preoperative breast cancer pain involves an inflammatory process

Researchers from the University of California San Francisco studied a sample of women scheduled for breast cancer surgery and sought to determine the occurrence rate for preoperative breast pain, describe characteristics of the pain, evaluate the demographic and clinical variation in the women with preoperative pain, and assess the role of in pro-and anti inflammatory cytokine genes.

5 Jun 2012

Cannabinoid therapy helps provide effective analgesia for cancer patients with pain

An investigational cannabinoid therapy helped provide effective analgesia when used as an adjuvant medication for cancer patients with pain that responded poorly to opioids, according to results of a multicenter trial reported in The Journal of Pain, published by the American Pain Society.

5 Jun 2012

ProStrakan, Orexo reconfigure commercial rights to Abstral

Orexo AB and ProStrakan Group plc jointly announce today that the companies have reconfigured the commercial rights to the product, Abstral, in various territories worldwide.

4 Jun 2012

Exercise reduces expression of cytokines and alleviates neuropathic pain

Exercise helps to alleviate pain related to nerve damage (neuropathic pain) by reducing levels of certain inflammation-promoting factors, suggests an experimental study in the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

2 Jun 2012

NYU Langone establishes unique neuromodulation center

The Department of Neurosurgery at NYU Langone Medical Center has established a unique, multidisciplinary neuromodulation center for the treatment of complex neurological conditions including movement disorders like Parkinson's disease, chronic pain and psychiatric condition such as obsessive compulsive disorder and severe depression.

31 May 2012

NIH Consortium selects UBM among 11 CoEPEs

With more Americans than ever living with chronic pain, the National Institutes of Health (NIH) Pain Consortium wants the University of Maryland, Baltimore (UMB) and 10 other health professional schools to teach the next generation of health care providers to be better equipped to manage and treat such patients.

25 May 2012

UCSF scientists aim to use embryonic stem cells for treatment of neuropathic pain

Chronic pain, by definition, is difficult to manage, but a new study by UCSF scientists shows how a cell therapy might one day be used not only to quell some common types of persistent and difficult-to-treat pain, but also to cure the conditions that give rise to them.

25 May 2012

Nevro to initiate Senza HF-SCS System study for chronic pain

Nevro Corp., a medical device company focused on achieving improved pain relief for patients suffering from debilitating chronic pain, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro's high-frequency spinal cord stimulation system for the treatment of chronic pain.

24 May 2012

USPTO issues patent to QRxPharma’s MoxDuo for treatment of acute and chronic pain

QRxPharma Limited announced today that the United States Patent and Trademark Office (USPTO) issued the Company U.S. Patent No. 8,182,837, which does not expire until 2023.

24 May 2012

NIH Pain Consortium selects 11 health professional schools as CoEPEs

The National Institutes of Health Pain Consortium has selected 11 health professional schools as designated Centers of Excellence in Pain Education (CoEPEs).

23 May 2012

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

Purdue Pharma L.P. will present an analysis of data from completed clinical trials for Butrans® (buprenorphine) Transdermal System CIII at the American Pain Society's (APS) 31st Annual Scientific Meeting.

19 May 2012

JAT accepts five scientific articles co-authored by UCSD doctoral pharmacy students

The Millennium Research Institute (MRI), a nonprofit national research center formed in 2010, and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego (UCSD) announced today five scientific articles co-authored by UCSD doctoral pharmacy students have been accepted by the Journal of Analytical Toxicology.

19 May 2012

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society (APS), honored the recipients of its sixth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

19 May 2012

Study focuses on role of the brain and mind in chronic and complex pain disorders

Training the brain to reduce pain could be a promising approach for treating phantom limb pain and complex regional pain syndrome, according to an internationally known neuroscience researcher speaking today at the American Pain Society's Annual Scientific Meeting.

19 May 2012

Two major reasons to monitor medication use in older patients with chronic pain

Ameritox, the nation's leader in pain medication monitoring, announced today the presentation of a peer-reviewed scientific poster titled "Patterns of Drug Use in the Older Chronic Pain Population" at the American Pain Society Annual Meeting.

18 May 2012

Migraine is a neurological, not vascular, disorder

The latest genetic and biological research shows that migraine is a neurological, not vascular, disorder and both acute and preventive treatments being developed target peripheral and central nervous systems, according to a prominent migraine expert addressing the American Pain Society (APS)today.

18 May 2012

ACO model may improve populations-based outcomes for pain management

How will pain care be influenced by the anticipated reforms in the U.S. healthcare system? Current models of healthcare delivery offer both obstacles and opportunities for achieving quality and effectiveness in pain-related care, according to Daniel Carr, MD, Tufts University in his keynote address at the American Pain Society Annual Scientific Meeting.

18 May 2012

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

Janssen Pharmaceuticals, Inc. today announced the results of an investigational Phase 3 study suggesting NUCYNTA ER (tapentadol) extended-release tablets were significantly more effective than placebo in providing pain management among adults with chronic moderate to severe, painful diabetic peripheral neuropathy.

18 May 2012

APS announces recipients of prestigious achievement awards

The American Pain Society (APS), www.ampainsoc.org, today announced the recipients of its prestigious achievement awards during the organization's annual scientific meeting. APS rewards excellence in pain management with awards for career achievement, pain scholarship, education and public service, advocacy on behalf of children, outstanding service to APS, early career achievements and journalism.

18 May 2012

Illinois Back Institute offers non-surgical treatment for lower back pain

Chronic pain is terrifying. Sciatica and stenosis are two of the most common causes of persistent, debilitating back pain. Chicago resident Pedro Estrada suffered from extreme back pain that compromised his livelihood and soured his outlook on life. After taking time off from his job and consulting many doctors, he finally found relief with non-surgical treatment at the Illinois Back Institute.

17 May 2012

Chronic Pain News and Research

Preoperative breast cancer pain involves an inflammatory process

Cannabinoid therapy helps provide effective analgesia for cancer patients with pain

ProStrakan, Orexo reconfigure commercial rights to Abstral

Exercise reduces expression of cytokines and alleviates neuropathic pain

NYU Langone establishes unique neuromodulation center

NIH Consortium selects UBM among 11 CoEPEs

UCSF scientists aim to use embryonic stem cells for treatment of neuropathic pain

Nevro to initiate Senza HF-SCS System study for chronic pain

USPTO issues patent to QRxPharma’s MoxDuo for treatment of acute and chronic pain

NIH Pain Consortium selects 11 health professional schools as CoEPEs

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

JAT accepts five scientific articles co-authored by UCSD doctoral pharmacy students

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

Study focuses on role of the brain and mind in chronic and complex pain disorders

Two major reasons to monitor medication use in older patients with chronic pain

Migraine is a neurological, not vascular, disorder

ACO model may improve populations-based outcomes for pain management

Janssen’s NUCYNTA ER tablets more effective in providing pain management in adults with DPN

APS announces recipients of prestigious achievement awards

Illinois Back Institute offers non-surgical treatment for lower back pain

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News